Results
|
3121.
|
|
|
3122.
|
Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer. [electronic resource] by
- Enwere, Emeka K
- Kornaga, Elizabeth N
- Dean, Michelle
- Koulis, Theodora A
- Phan, Tien
- Kalantarian, Maria
- Köbel, Martin
- Ghatage, Prafull
- Magliocco, Anthony M
- Lees-Miller, Susan P
- Doll, Corinne M
Producer: 20180222
In:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 30
Availability: No items available.
|
|
3123.
|
|
|
3124.
|
MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer. [electronic resource] by
- Bouillez, A
- Rajabi, H
- Jin, C
- Samur, M
- Tagde, A
- Alam, M
- Hiraki, M
- Maeda, T
- Hu, X
- Adeegbe, D
- Kharbanda, S
- Wong, K-K
- Kufe, D
Producer: 20170929
In:
Oncogene vol. 36
Availability: No items available.
|
|
3125.
|
|
|
3126.
|
Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. [electronic resource] by
- Sridharan, Vishwajith
- Gjini, Evisa
- Liao, Xiaoyun
- Chau, Nicole G
- Haddad, Robert I
- Severgnini, Mariano
- Hammerman, Peter
- El-Naggar, Adel
- Freeman, Gordon J
- Hodi, F Stephen
- Rodig, Scott J
- Dranoff, Glenn
- Schoenfeld, Jonathan D
Producer: 20171121
In:
Cancer immunology research vol. 4
Availability: No items available.
|
|
3127.
|
Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer. [electronic resource] by
- Sheffield, Brandon S
- Fulton, Regan
- Kalloger, Steve E
- Milne, Katy
- Geller, Georgia
- Jones, Martin
- Jacquemont, Celine
- Zachara, Susanna
- Zhao, Eric
- Pleasance, Erin
- Laskin, Janessa
- Jones, Steven J M
- Marra, Marco A
- Yip, Stephen
- Nelson, Brad H
- Gown, Allen M
- Ho, Cheryl
- Ionescu, Diana N
Producer: 20170524
In:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society vol. 64
Availability: No items available.
|
|
3128.
|
Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung. [electronic resource] by
- Ueda, Takuya
- Aokage, Keiju
- Nishikawa, Hiroyoshi
- Neri, Shinya
- Nakamura, Hiroshi
- Sugano, Masato
- Tane, Kenta
- Miyoshi, Tomohiro
- Kojima, Motohiro
- Fujii, Satoshi
- Kuwata, Takeshi
- Ochiai, Atsushi
- Kusumoto, Masahiko
- Suzuki, Kenji
- Tsuboi, Masahiro
- Ishii, Genichiro
Producer: 20180507
In:
Journal of cancer research and clinical oncology vol. 144
Availability: No items available.
|
|
3129.
|
|
|
3130.
|
|
|
3131.
|
|
|
3132.
|
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial. [electronic resource] by
- Frenel, Jean-Sebastien
- Le Tourneau, Christophe
- O'Neil, Bert
- Ott, Patrick A
- Piha-Paul, Sarina A
- Gomez-Roca, Carlos
- van Brummelen, Emilie M J
- Rugo, Hope S
- Thomas, Shari
- Saraf, Sanatan
- Rangwala, Reshma
- Varga, Andrea
Producer: 20171219
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
3133.
|
Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM). [electronic resource] by
- Cedrés, S
- Ponce-Aix, S
- Pardo-Aranda, N
- Navarro-Mendivil, A
- Martinez-Marti, A
- Zugazagoitia, J
- Sansano, I
- Montoro, M A
- Enguita, A
- Felip, E
Producer: 20171218
In:
Lung cancer (Amsterdam, Netherlands) vol. 96
Availability: No items available.
|
|
3134.
|
|
|
3135.
|
|
|
3136.
|
|
|
3137.
|
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome. [electronic resource] by
- Arias-Pulido, H
- Cimino-Mathews, A
- Chaher, N
- Qualls, C
- Joste, N
- Colpaert, C
- Marotti, J D
- Foisey, M
- Prossnitz, E R
- Emens, L A
- Fiering, S
Producer: 20190306
In:
Breast cancer research and treatment vol. 171
Availability: No items available.
|
|
3138.
|
|
|
3139.
|
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. [electronic resource] by
- Gandara, David R
- Paul, Sarah M
- Kowanetz, Marcin
- Schleifman, Erica
- Zou, Wei
- Li, Yan
- Rittmeyer, Achim
- Fehrenbacher, Louis
- Otto, Geoff
- Malboeuf, Christine
- Lieber, Daniel S
- Lipson, Doron
- Silterra, Jacob
- Amler, Lukas
- Riehl, Todd
- Cummings, Craig A
- Hegde, Priti S
- Sandler, Alan
- Ballinger, Marcus
- Fabrizio, David
- Mok, Tony
- Shames, David S
Producer: 20190513
In:
Nature medicine vol. 24
Availability: No items available.
|
|
3140.
|
|